GB201808567D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB201808567D0
GB201808567D0 GBGB1808567.0A GB201808567A GB201808567D0 GB 201808567 D0 GB201808567 D0 GB 201808567D0 GB 201808567 A GB201808567 A GB 201808567A GB 201808567 D0 GB201808567 D0 GB 201808567D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808567.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Douglas Pharmaceuticals Ltd
Original Assignee
Douglas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Douglas Pharmaceuticals Ltd filed Critical Douglas Pharmaceuticals Ltd
Priority to GBGB1808567.0A priority Critical patent/GB201808567D0/en
Publication of GB201808567D0 publication Critical patent/GB201808567D0/en
Priority to PCT/IB2019/054289 priority patent/WO2019224776A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
GBGB1808567.0A 2018-05-24 2018-05-24 Pharmaceutical compositions Ceased GB201808567D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1808567.0A GB201808567D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions
PCT/IB2019/054289 WO2019224776A1 (en) 2018-05-24 2019-05-23 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808567.0A GB201808567D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB201808567D0 true GB201808567D0 (en) 2018-07-11

Family

ID=62812390

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808567.0A Ceased GB201808567D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions

Country Status (2)

Country Link
GB (1) GB201808567D0 (en)
WO (1) WO2019224776A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201808564D0 (en) 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Treatments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284874B1 (en) * 1996-08-02 1998-05-22 Farmigea Spa BIOADHESIVE COMPLEXES OF POLYCARBOPHIL AND AZOLIC ANTIFUNGAL OR ANTIPROTOZOAR DRUGS
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
AU2003233653B2 (en) * 2002-05-23 2008-08-07 Umd, Inc. Compositions and method for transmucosal drug delivery and cryoprotection
US20040033968A1 (en) * 2002-08-16 2004-02-19 Lin Shun Y. Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
AU2006209263A1 (en) * 2005-09-12 2007-03-29 Mcneil-Ppc, Inc. Anhydrous composition containing an acid-acid buffer system
US20070298087A1 (en) * 2006-06-27 2007-12-27 Biegajski James E Two-phase mucoadhesive composition
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
EP2729131B1 (en) * 2011-07-05 2020-04-15 Novan, Inc. Topical compositions
EP3603637A1 (en) * 2013-10-23 2020-02-05 The University of Manchester Treatment of cancer and benign proliferative disorders

Also Published As

Publication number Publication date
WO2019224776A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
IL271657A (en) Pharmaceutical compositions
IL271759A (en) Pharmaceutical compositions comprising entrectinib
GB201804548D0 (en) Pharmaceutical compositions
GB201705303D0 (en) Pharmaceutical compositions
SG11202001179YA (en) Pharmaceutical compositions
GB201705305D0 (en) Pharmaceutical compositions
GB201807053D0 (en) Pharmaceutical composition
GB201705304D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
SG11202103374TA (en) Pharmaceutical composition
GB201911517D0 (en) Pharmaceutical composition
GB201808571D0 (en) Pharmaceutical compositions
EP3727485C0 (en) Pharmaceutical composition
EP4081251A4 (en) Pharmaceutical compositions
IL272044A (en) Pharmaceutical compositions
SG11202110315SA (en) Pharmaceutical composition
FI3908321T3 (en) Pharmaceutical composition
GB201808567D0 (en) Pharmaceutical compositions
GB201810109D0 (en) Pharmaceutical compositions
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
IL272428A (en) Pharmaceutical compositions
GB201810261D0 (en) New pharmaceutical compositions
GB201810265D0 (en) New pharmaceutical compositions
ZA202000014B (en) Pharmaceutical compositions
GB201820689D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)